11-Substituted Benzo[c]phenanthridines: New Structures and Insight into Their Mode of Antiproliferative Action.

作者: Bernd Clement , Ulrich Girreser , Tamara N. Steinhauer , Christopher Meier , Doris Marko

DOI: 10.1002/CMDC.201600199

关键词: DrugHuman tumorDevelopmental Therapeutics ProgramTubulinCell cultureTopoisomeraseGrowth inhibitionStereochemistryMultiple drug resistanceChemistry

摘要: The synthesis of various new structures a library 11-substituted 6-amino-11,12-dihydrobenzo[c]phenanthridines (BP) and 6-aminobenzo[c]phenanthridines (BP-D) is presented. These structures, further synthetic modifications, the preparation follow-up products which delivered about 40 derivatives are described. Their potential as antiproliferative drug candidates was investigated by comparison NCI 60 developmental therapeutics program (DTP) human tumor cell line screening data based on results in vitro growth inhibition, including hitherto unpublished compound test with up to cancer lines. NCI-COMPARE studies helped suggest modes action highly active drugs. findings supported biological investigations showing either inhibition tubulin polymerization depolymerization or topoisomerase inhibition. Together physicochemical parameters candidates, structure–activity relationships critically discussed. Tubulin interaction topoisomerase I IIα/β activity two rationales that can explain observed in DTP screen. However, it also be reasonably assumed these compounds address several targets, thus prohibiting identification simple relationships. described herein thought act so-called multitarget drugs, being special interest area multidrug resistance.

参考文章(50)
Adrien Albert, E. P. Serjeant, Determination of ionization constants by spectrophotometry Springer, Dordrecht. pp. 70- 101 ,(1984) , 10.1007/978-94-009-5548-6_4
Katrin Palm, Patric Stenberg, Kristina Luthman, Per Artursson1, Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans Pharmaceutical Research. ,vol. 14, pp. 568- 571 ,(1997) , 10.1023/A:1012188625088
Zhi-Jie Hou, Xi Luo, Wei Zhang, Fei Peng, Bai Cui, Si-Jin Wu, Fei-Meng Zheng, Jie Xu, Ling-Zhi Xu, Zi-Jie Long, Xue-Ting Wang, Guo-Hui Li, Xian-Yao Wan, Yong-Liang Yang, Quentin Liu, Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells Oncotarget. ,vol. 6, pp. 6326- 6340 ,(2015) , 10.18632/ONCOTARGET.3436
Carmen J Booth, Yanfeng Liu, Sara Rockwell, Qiwen Duan, Use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies. Journal of The American Association for Laboratory Animal Science. ,vol. 51, pp. 224- 230 ,(2012)
Li-Ping Bai, Masaki Hagihara, Kazuhiko Nakatani, Zhi-Hong Jiang, Recognition of Chelerythrine to Human Telomeric DNA and RNA G-quadruplexes Scientific Reports. ,vol. 4, pp. 6767- 6767 ,(2015) , 10.1038/SREP06767
Bernd Clement, Matthias Weide, Ulrich Wolschendorf, Ilka Kock, A Two-Step Synthesis of Cytostatically Active Benzo[c]phenanthridine Derivatives Angewandte Chemie International Edition. ,vol. 44, pp. 635- 638 ,(2005) , 10.1002/ANIE.200461969
Kazumasa TAKAHASHI, Takafusa OKAMOTO, Kazutoshi YAMADA, Hirotada IIDA, A Convenient Synthesis of Substituted Stilbenes by Condensation of o- or p-Tolunitrile with p-Substituted Benzaldehydes1,2 Synthesis. ,vol. 1977, pp. 58- 59 ,(1977) , 10.1055/S-1977-24278
Fabrice Fleury, Alyona Sukhanova, Anatoli Ianoul, Jerome Devy, Irina Kudelina, Olivier Duval, Alain J. P. Alix, Jean Claude Jardillier, Igor Nabiev, Molecular Determinants of Site-specific Inhibition of Human DNA Topoisomerase I by Fagaronine and Ethoxidine Journal of Biological Chemistry. ,vol. 275, pp. 3501- 3509 ,(2000) , 10.1074/JBC.275.5.3501
Annette Kragh Larsen, Lucile Grondard, Jeannine Couprie, Bernard Desoize, Leopold Comoe, Jean-Claude Jardillier, Jean-François Riou, The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II Biochemical Pharmacology. ,vol. 46, pp. 1403- 1412 ,(1993) , 10.1016/0006-2952(93)90105-6